Celcuity CELC
NASDAQ CELC
$94.63 -1.81 (-1.87%)
As of: Sep 4, 2026 · 12:52 PM EDT

Celcuity (CELC) Income towards Parent Company (2016 - 2026)

Celcuity's (CELC) quarterly Income towards Parent Company came in at -$51.0 million in Q4 2025, down 39.07% YoY from -$83.7 million in Q4 2024, and down 16.37% on a QoQ basis from -$43.8 million in Q3 2025.

Analysis

Celcuity (CELC) Income towards Parent Company (2016 - 2026) Analysis & Trends

Celcuity (CELC) has 10 years of Income towards Parent Company data on file, last reported at -$51.0 million in Q4 2025.

  • Quarterly Income towards Parent Company fell 39.07% year-over-year to -$51.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$177.0 million (down 58.39% YoY) and the FY2025 annual result came in at -$139.9 million, down 24.38% from the prior year.
  • Income towards Parent Company retreated to -$51.0 million in Q4 2025, from -$43.8 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of -$2.8 million in Q1 2021 to a low of -$51.0 million in Q4 2025.
  • A 5-year average of -$21.1 million and a median of -$16.5 million in 2023 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2021 — Income towards Parent Company slumped 1104.06% — and 2022, when it rose 29.02%.
  • Tracing CELC's Income towards Parent Company over 5 years: stood at -$6.8 million in 2021, then plunged by 71.49% to -$11.6 million in 2022, then slumped by 62.75% to -$18.8 million in 2023, then plunged by 94.46% to -$36.7 million in 2024, then plunged by 39.07% to -$51.0 million in 2025.
  • The last three Income towards Parent Company figures came in at -$51.0 million (Q4 2025), -$43.8 million (Q3 2025), and -$45.3 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn -
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn
10 Celcuity 5.19 Bn 5.19 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -78.86 Mn
Dec 31, 2025 -50.97 Mn
Sep 30, 2025 -43.80 Mn
Jun 30, 2025 -45.27 Mn
Mar 31, 2025 -37.00 Mn
Dec 31, 2024 -36.65 Mn
Sep 30, 2024 -29.79 Mn
Jun 30, 2024 -23.72 Mn
Mar 31, 2024 -21.61 Mn
Dec 31, 2023 -18.85 Mn
Sep 30, 2023 -18.40 Mn
Jun 30, 2023 -14.59 Mn
Mar 31, 2023 -11.94 Mn
Dec 31, 2022 -11.58 Mn
Sep 30, 2022 -10.89 Mn
Jun 30, 2022 -9.96 Mn
Mar 31, 2022 -7.93 Mn
Dec 31, 2021 -6.75 Mn
Sep 30, 2021 -6.03 Mn
Jun 30, 2021 -14.03 Mn